Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Parizot

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|May 27, 2021
Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapiesAurélien Corneau, Christophe Parizot, Mustapha Cherai, et al.
Cytotherapy|June 22, 2025
CD8 and CD4 CAR-T cells are associated with outcome and toxicity of tisagenlecleucel in central nervous system lymphomaJules Al Samara, Marine Baron, Marianne Gazzano, et al.
Plos One|August 14, 2020
Identification of peptides interfering with the LRRK2/PP1 interactionChang Zhi Dong, Heriberto Bruzzoni-Giovanelli, Yanhua Yu, et al.
Plos One|January 6, 2012
Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational studyVirginie Lvovschi, Laurent Arnaud, Christophe Parizot, et al.
The Journal of Experimental Medicine|January 25, 2006
The immune paradox of sarcoidosis and regulatory T cellsMakoto Miyara, Zahir Amoura, Christophe Parizot, et al.
Plos Pathogens|October 27, 2011
Exhausted cytotoxic control of Epstein-Barr virus in human lupusMartin Larsen, Delphine Sauce, Claire Deback, et al.
Annals of the Rheumatic Diseases|June 15, 2012
Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesionsAlexis Mathian, Christophe Parizot, Karim Dorgham, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Blood|January 6, 2011
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patientsLaurent Arnaud, Guy Gorochov, Frédéric Charlotte, et al.
European Journal of Immunology|June 21, 2011
Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsetsMartin Larsen, Laurent Arnaud, Miguel Hié, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 27, 2021
Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapiesAurélien Corneau, Christophe Parizot, Mustapha Cherai, et al.
Cytotherapy|June 22, 2025
CD8 and CD4 CAR-T cells are associated with outcome and toxicity of tisagenlecleucel in central nervous system lymphomaJules Al Samara, Marine Baron, Marianne Gazzano, et al.
Plos One|August 14, 2020
Identification of peptides interfering with the LRRK2/PP1 interactionChang Zhi Dong, Heriberto Bruzzoni-Giovanelli, Yanhua Yu, et al.
Plos One|January 6, 2012
Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational studyVirginie Lvovschi, Laurent Arnaud, Christophe Parizot, et al.
The Journal of Experimental Medicine|January 25, 2006
The immune paradox of sarcoidosis and regulatory T cellsMakoto Miyara, Zahir Amoura, Christophe Parizot, et al.
Plos Pathogens|October 27, 2011
Exhausted cytotoxic control of Epstein-Barr virus in human lupusMartin Larsen, Delphine Sauce, Claire Deback, et al.
Annals of the Rheumatic Diseases|June 15, 2012
Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesionsAlexis Mathian, Christophe Parizot, Karim Dorgham, et al.
AIDS (London, England)|July 18, 2015
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremiaAmélie Guihot, Chiara Dentone, Lambert Assoumou, et al.
Blood|January 6, 2011
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patientsLaurent Arnaud, Guy Gorochov, Frédéric Charlotte, et al.
European Journal of Immunology|June 21, 2011
Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsetsMartin Larsen, Laurent Arnaud, Miguel Hié, et al.
Pageof 6